Implantable defibrillators is a battery-powered small device placed underneath chest or abdomen to keep track of patient’s heart rate. Increase in palpitation is diagnosed by the device and the normal heart rhythm is restored. These devices play a vital role in preventing sudden cardiac arrest in patients who suffer from sustained ventricular tachycardia or atrial fibrillation. Therefore, ICDs constantly monitor the heart rhythm through electrodes and deliver treatments when abnormal heart rhythm is detected. The treatments through ICDs include pacing, cardioversion, and defibrillation to restore normal heart rhythm. Research Beam Model: Research Beam Product ID: 1517056 5370 USD New
Implantable Defibrillators Market by Product Type [Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), and Cardiac Resynchronization Therapy Defibrillator (CRT-D)] and Geography (North America, Europe, Asia-Pacific, and LAMEA) - Global Opportunity Analysis and Industry Forecast, 2014-2022
 

Implantable Defibrillators Market by Product Type [Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), and Cardiac Resynchronization Therapy Defibrillator (CRT-D)] and Geography (North America, Europe, Asia-Pacific, and LAMEA) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Implantable Defibrillators Market by Product Type [Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter

Category : Medical Devices
Published On : April  2017
Pages : 150

request-discount


TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

Implantable defibrillators is a battery-powered small device placed underneath chest or abdomen to keep track of patient’s heart rate. Increase in palpitation is diagnosed by the device and the normal heart rhythm is restored. These devices play a vital role in preventing sudden cardiac arrest in patients who suffer from sustained ventricular tachycardia or atrial fibrillation. Therefore, ICDs constantly monitor the heart rhythm through electrodes and deliver treatments when abnormal heart rhythm is detected. The treatments through ICDs include pacing, cardioversion, and defibrillation to restore normal heart rhythm.

The implantable defibrillator market was valued at $6,006 million in 2015, and is projected to reach $8,449 million by 2022, growing at a CAGR of 4.9% from 2016 to 2022. This is attributed to the advancements in the technology such as introduction of quadripolar lead devices to improve device programming, extend battery life, and development of magnetic resonance imaging (MRI)-safe ICDs. In addition, rise in incidence of atrial fibrillation and high risk of sudden cardiac arrest (SCA) fuel the demand for implantable defibrillator devices. Furthermore, introduction of subcutaneous ICD technology in 2012 has revolutionized the treatment technology for cardiac rhythm management through these devices. Boston Scientific’s S-ICDs was granted market clearance in 2012, which was the first commercially available S-ICDs system worldwide. S-ICDs are widely adopted, as they are implanted below the skin without the leads to be placed inside the heart. This fueled the demand for S-ICDs globally, thus driving the growth of the market. However, presence of alternative treatment and limited insurance coverage are projected to hamper the market growth.

The implantable defibrillator market is segmented based on product type and geography. On the basis of product type, the market is segmented into transvenous implantable cardioverter-defibrillator (T-ICDs), subcutaneous implantable cardioverter defibrillators (S-ICDS), and cardiac resynchronization therapy defibrillator (CRT-D). Geographically, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Argentina, Egypt, Israel, South Africa, and rest of LAMEA).

KEY BENEFITS

  • This report provides an extensive analysis of the current & emerging market trends and dynamics in the global implantable defibrillator market.
  • Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
  • This report entails the detailed quantitative analysis of the current trends and future estimations to identify the prevailing opportunities.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.
  • Region- and country-wise market conditions are analyzed in the report.

KEY MARKET SEGMENTS

By Product Type

  • Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
  • Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
  • Cardiac Resynchronization Therapy Defibrillator (CRT-D)

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Argentina
    • Egypt
    • Israel
    • South Africa
    • Rest of LAMEA

KEY PLAYERS

  • Boston Scientific Corporation
  • LivaNova PLC Company
  • Imricor Medical Systems
  • MicroPort Scientific Corporation
  • Mayo Clinic US
  • Medtronic Plc
  • MRI Interventions, Inc.
  • St. Jude Medical, Inc.
  • Biotronik Se & Co.KG
  • Sorin Group

CHAPTER 1 INTRODUCTION

1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. KEY PLAYERS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.2.3. Top player positioning

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Rising incidence of sudden cardiac arrest (SCA)
3.3.1.2. Technologically advanced implantable defibrillators
3.3.1.3. Presence of high unmet medical needs

3.3.2. Restraints

3.3.2.1. Limited insurance coverage
3.3.2.2. Presence of alternative mode of treatment

3.3.3. Opportunities

3.3.3.1. Lucrative opportunities in emerging economies

CHAPTER 4 IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT TYPE

4.1. OVERVIEW

4.1.1. Key market trends
4.1.2. Growth factors and opportunities
4.1.3. Market size and forecast

4.2. SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (S-ICDS)

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. TRANSVENOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (T-ICDS)

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D)

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

CHAPTER 5 IMPLANTABLE DEFIBRILLATORS MARKET, BY REGION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Growth factors and opportunities
5.2.3. Market size and forecast by Country
5.2.4. Market size and forecast by Product

5.2.4.1. U.S. market size and forecast
5.2.4.2. Canada market size and forecast
5.2.4.3. Mexico market size and forecast

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast by Country
5.3.4. Market size and forecast by Product

5.3.4.1. UK market size and forecast
5.3.4.2. Germany market size and forecast
5.3.4.3. France market size and forecast
5.3.4.4. Italy market size and forecast
5.3.4.5. Spain market size and forecast
5.3.4.6. Rest of Europe market size and forecast

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.2. Growth factors and opportunities
5.4.3. Market size and forecast by Country
5.4.4. Market size and forecast by Product

5.4.4.1. Japan market size and forecast
5.4.4.2. India market size and forecast
5.4.4.3. China market size and forecast
5.4.4.4. Australia market size and forecast
5.4.4.5. Rest of Asia-Pacific market size and forecast

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Growth factors and opportunities
5.5.3. Market size and forecast by Country
5.5.4. Market size and forecast by Product

5.5.4.1. Brazil market size and forecast
5.5.4.2. Argentina market size and forecast
5.5.4.3. Egypt market size and forecast
5.5.4.4. Israel market size and forecast
5.5.4.5. South Africa market size and forecast
5.5.4.6. Rest of LAMEA market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1. BOSTON SCIENTIFIC CORPORATION

6.1.1. Company overview
6.1.2. Operating business segments
6.1.3. Business performance
6.1.4. Key strategic moves and developments

6.2. LIVANOVA PLC COMPANY

6.2.1. Company overview
6.2.2. Operating business segments
6.2.3. Business performance
6.2.4. Key strategic moves and developments

6.3. IMRICOR MEDICAL SYSTEMS

6.3.1. Company overview
6.3.2. Operating business segments
6.3.3. Business performance
6.3.4. Key strategic moves and developments

6.4. MICROPORT SCIENTIFIC CORPORATION

6.4.1. Company overview
6.4.2. Operating business segments
6.4.3. Business performance
6.4.4. Key strategic moves and developments

6.5. MAYO CLINIC US

6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves and developments

6.6. MEDTRONIC PLC

6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. Business performance
6.6.4. Key strategic moves and developments

6.7. MRI INTERVENTIONS, INC.

6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Business performance
6.7.4. Key strategic moves and developments

6.8. ST. JUDE MEDICAL, INC.

6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Business performance
6.8.4. Key strategic moves and developments

6.9. BIOTRONIK SE & CO.KG

6.9.1. Company overview
6.9.2. Operating business segments
6.9.3. Business performance
6.9.4. Key strategic moves and developments

6.10. SORIN GROUP

6.10.1. Company overview
6.10.2. Operating business segments
6.10.3. Business performance
6.10.4. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 2. GLOBAL IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT TYPE, 2014-2022 (THOUSAND UNIT)
TABLE 3. SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (S-ICDS) MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 4. SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (S-ICDS) MARKET, BY REGION, 2014-2022 (THOUSAND UNIT)
TABLE 5. TRANSVENOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (T-ICDS) MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 6. TRANSVENOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (T-ICDS) MARKET, BY REGION, 2014-2022 (THOUSAND UNIT)
TABLE 7. CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 8. CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) MARKET, BY REGION, 2014-2022 (THOUSAND UNIT)
TABLE 9. GLOBAL IMPLANTABLE DEFIBRILLATORS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 10. GLOBAL IMPLANTABLE DEFIBRILLATORS MARKET, BY REGION, 2014-2022 (THOUSAND UNIT)
TABLE 11. NORTH AMERICA IMPLANTABLE DEFIBRILLATORS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 12. NORTH AMERICA IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 13. NORTH AMERICA IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT, 2014-2022 (THOUSAND UNIT)
TABLE 14. EUROPE IMPLANTABLE DEFIBRILLATORS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 15. EUROPE IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 16. EUROPE IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT, 2014-2022 (THOUSAND UNIT)
TABLE 17. ASIA-PACIFIC IMPLANTABLE DEFIBRILLATORS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 18. ASIA-PACIFIC IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 19. ASIA-PACIFIC IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT, 2014-2022 (THOUSAND UNIT)
TABLE 20. LAMEA IMPLANTABLE DEFIBRILLATORS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 21. LAMEA IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 22. LAMEA IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT, 2014-2022 (THOUSAND UNIT)
TABLE 23. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 24. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 25. LIVANOVA: COMPANY SNAPSHOT
TABLE 26. LIVANOVA: OPERATING SEGMENTS
TABLE 27. IMRICOR: COMPANY SNAPSHOT
TABLE 28. IMRICOR: OPERATING SEGMENTS
TABLE 29. MICROPORT: COMPANY SNAPSHOT
TABLE 30. MICROPORT: OPERATING SEGMENTS
TABLE 31. MAYO CLINIC: COMPANY SNAPSHOT
TABLE 32. MAYO CLINIC: OPERATING SEGMENTS
TABLE 33. MEDTRONIC: COMPANY SNAPSHOT
TABLE 34. MEDTRONIC: OPERATING SEGMENTS
TABLE 35. MRI INTERVENTIONS: COMPANY SNAPSHOT
TABLE 36. MRI INTERVENTIONS: OPERATING SEGMENTS
TABLE 37. ST. JUDE MEDICAL: COMPANY SNAPSHOT
TABLE 38. ST. JUDE MEDICAL: OPERATING SEGMENTS
TABLE 39. BIOTRONIK: COMPANY SNAPSHOT
TABLE 40. BIOTRONIK: OPERATING SEGMENTS
TABLE 41. SORIN GROUP: COMPANY SNAPSHOT
TABLE 42. SORIN GROUP: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. GLOBAL IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT TYPE, 2015 VS 2022 ($MILLION)
FIGURE 2. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2014-2016
FIGURE 3. TOP WINNING STRATEGIES: BY NATURE, & TYPE OF DEVELOPMENT, 2014-2016
FIGURE 4. TOP INVESTMENT POCKETS
FIGURE 5. TOP PLAYER POSITIONING: GLOBAL IMPLANTABLE DEFIBRILLATORS MARKET, 2015
FIGURE 6. U.S. IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 7. CANADA IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 8. MEXICO IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 9. UK IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 10. GERMANY IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 11. FRANCE IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 12. ITALY IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 13. SPAIN IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 14. REST OF EUROPE IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 15. JAPAN IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 16. INDIA IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 17. CHINA IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 18. AUSTRALIA IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 19. REST OF ASIA-PACIFIC IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 20. BRAZIL IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 21. ARGENTINA IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 22. EGYPT IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 23. ISRAEL IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 24. SOUTH AFRICA IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 25. REST OF LAMEA IMPLANTABLE DEFIBRILLATORS MARKET, 2014-2022 ($MILLION)
FIGURE 26. BOSTON SCIENTIFIC: REVENUE, 2014-2016 ($MILLION)
FIGURE 27. BOSTON SCIENTIFIC: REVENUE BY SEGMENT, 2016 (%)
FIGURE 28. BOSTON SCIENTIFIC: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 29. LIVANOVA: REVENUE, 2014-2016 ($MILLION)
FIGURE 30. LIVANOVA: REVENUE BY SEGMENT, 2016 (%)
FIGURE 31. LIVANOVA: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 32. IMRICOR: REVENUE, 2014-2016 ($MILLION)
FIGURE 33. IMRICOR: REVENUE BY SEGMENT, 2016 (%)
FIGURE 34. IMRICOR: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 35. MICROPORT: REVENUE, 2014-2016 ($MILLION)
FIGURE 36. MICROPORT: REVENUE BY SEGMENT, 2016 (%)
FIGURE 37. MICROPORT: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 38. MAYO CLINIC: REVENUE, 2014-2016 ($MILLION)
FIGURE 39. MAYO CLINIC: REVENUE BY SEGMENT, 2016 (%)
FIGURE 40. MAYO CLINIC: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 41. MEDTRONIC: REVENUE, 2014-2016 ($MILLION)
FIGURE 42. MEDTRONIC: REVENUE BY SEGMENT, 2016 (%)
FIGURE 43. MEDTRONIC: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 44. MRI INTERVENTIONS: REVENUE, 2014-2016 ($MILLION)
FIGURE 45. MRI INTERVENTIONS: REVENUE BY SEGMENT, 2016 (%)
FIGURE 46. MRI INTERVENTIONS: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 47. ST. JUDE MEDICAL: REVENUE, 2014-2016 ($MILLION)
FIGURE 48. ST. JUDE MEDICAL: REVENUE BY SEGMENT, 2016 (%)
FIGURE 49. ST. JUDE MEDICAL: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 50. BIOTRONIK: REVENUE, 2014-2016 ($MILLION)
FIGURE 51. BIOTRONIK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 52. BIOTRONIK: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 53. SORIN GROUP: REVENUE, 2014-2016 ($MILLION)
FIGURE 54. SORIN GROUP: REVENUE BY SEGMENT, 2016 (%)
FIGURE 55. SORIN GROUP: REVENUE BY GEOGRAPHY, 2016 (%)

Enquiry Before Buy